Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2022 08:00 ET | Source: Vyant Bio, Inc.

Vyant Bio to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16

CHERRY HILL, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
November 01, 2022 08:00 ET | Source: Vyant Bio, Inc.

Vyant Bio Announces One-for-Five Reverse Stock Split

CHERRY HILL, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
August 22, 2022 16:10 ET | Source: Vyant Bio, Inc.

Vyant Bio Reports Second Quarter and First Half 2022 Results and Provides Strategic and Business Highlights

Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights Based on preclinical efficacy data in our human Rett cortical organoid model, we are advancing VYNT0126 into...
November 10, 2021 16:15 ET | Source: Vyant Bio, Inc.

Vyant Bio to Present at the Q4 Investor Summit Micro & Small Cap Conference

Cherry Hill, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
November 09, 2021 09:15 ET | Source: Vyant Bio, Inc.

Vyant Bio Announces Investor Conference Call and Webcast for the Third Quarter 2021

CHERRY HILL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...